Show more

1) Today I was in London at the Royal Hospital for Integrated Medicine, Great Ormond Street, London. I had my regular, annual, Enroll-HD clinical research appointment. In addition to being a long-running Huntington’s Disease observational study, Enroll-HD is also a handy resource for HD researchers to help them identify HD patients that might be suitable for any HD research studies and/or clinical trials that they might be designing. You can find more info here: enroll-hd.org/

Part 2) I still feel in great shape, despite my participation in the trial having finished in July 2021. There is a new trial underway with tominersen called GENERATION-HD2. which you can read about in the link below to the HDBuzz article above.

Part 1) I took part in the Roche GENERATION-HD1 clinical trial evaluating the efficacy of the huntingtin-lowering drug, tominersen, for patients with Huntingtons Disease. After the trial had concluded, I found out that I was on the active drug (rather than the placebo). I'm not surprised as I really felt that my HD symptoms have improved considerably while on (and since) the trial.

en.hdbuzz.net/354

I'm back on social media after a couple of years break. Did I miss anything? 🤔 It's going to take a while for me to reestablish all of my connections.

Matt Ward

CounterSocial is the first Social Network Platform to take a zero-tolerance stance to hostile nations, bot accounts and trolls who are weaponizing OUR social media platforms and freedoms to engage in influence operations against us. And we're here to counter it.